Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€34.41
09.11.20
€40.00
09.11.21
18.27%
02.11.21

Could be very worthwhile Investment >20% year
Market Leader or Top 3
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Shopify Inc

Start price
Target price
Perf. (%)
€99.12
02.05.21
€120.00
02.11.21
33.58%
02.11.21

Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
High Investments for future growth
Very low/no dividend yield expected
buy
Cell Impact AB

Start price
Target price
Perf. (%)
€5.30
08.07.21
-
08.07.22
-14.30%
01.11.21

Could be worthwhile Investment >10% per year
buy
Hexagon Composites ASA

Start price
Target price
Perf. (%)
€3.68
08.07.21
-
08.07.22
0.38%
01.11.21

Could be worthwhile Investment >10% per year
buy
Powercell Sweden AB

Start price
Target price
Perf. (%)
€21.44
08.07.21
-
08.07.22
-8.58%
01.11.21

Could be worthwhile Investment >10% per year
JinkoSolar Holding Co. Ltd. ADR

Start price
Target price
Perf. (%)
€54.40
14.02.21
-
14.02.22
-3.86%
01.11.21

Sustainability is very important
Innovative
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Winfarm S.a.

Start price
Target price
Perf. (%)
€36.30
07.07.21
€38.00
07.07.22
-9.64%
01.11.21

Could be worthwhile Investment >10% per year
buy
Washington Prime Group Inc.

Start price
Target price
Perf. (%)
€1.56
08.03.21
€5.50
08.03.22
-53.85%
01.11.21

Differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
buy
Jumia Technologies AG

Start price
Target price
Perf. (%)
€22.70
18.05.21
€19.00
18.05.22
-33.26%
01.11.21

Good rating
Standard Investments for future growth
High valuation
Very low/no dividend yield expected
buy
iBio Inc.

Start price
Target price
Perf. (%)
€30.56
28.05.21
€25.00
28.05.22
-45.75%
01.11.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
Bitcoin Group SE

Start price
Target price
Perf. (%)
€42.00
13.06.21
€30.00
13.06.22
14.64%
01.11.21

Very low/no dividend yield expected
Bad rating
Risky balance sheet
ROE lower than 5% per year
buy
Modern Plant Based Foods Inc.

Start price
Target price
Perf. (%)
€2.34
20.01.21
€1.90
20.01.22
-51.70%
01.11.21

Could be worthwhile Investment >10% per year
High valuation
Very low/no dividend yield expected
negative Cash Flow expected
buy
Zynga Inc.

Start price
Target price
Perf. (%)
€9.00
07.02.21
€10.00
07.02.22
-30.00%
01.11.21

Capable Management
Very low/no dividend yield expected
Risky balance sheet
Few uniques
buy
Fastly Inc.

Start price
Target price
Perf. (%)
€67.50
19.08.20
€69.00
04.11.21
-34.74%
01.11.21

EBIT growth >5% per year expected
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
buy
TUI AG ADR

Start price
Target price
Perf. (%)
€1.63
22.08.20
€2.80
04.11.21
-14.29%
01.11.21

Revenue decline/stagnation expected
Increased challenges to pay loans and raise capital
Growths slower than the competition
Very high cyclical dependencies
buy
Kandi Technologies Corp.

Start price
Target price
Perf. (%)
€5.77
02.11.20
€4.90
04.11.21
-32.99%
01.11.21

EBIT growth >5% per year expected
Innovative
Future proof or reliable business model
Sustainability is little important
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€19.50
28.11.20
€23.00
28.11.21
-36.41%
01.11.21

Could be worthwhile Investment >10% per year
buy
TeamViewer AG

Start price
Target price
Perf. (%)
€28.94
11.12.19
€20.00
04.11.21
-56.03%
01.11.21

EBIT growth >5% per year expected
Normal challenges to pay loans and raise capital
ROE lower than 10% per year
Below average Management
buy
Hecla Mining Corp.

Start price
Target price
Perf. (%)
€5.85
29.07.21
€7.00
29.07.22
-14.27%
01.11.21

Very low/no dividend yield expected
negative Cash Flow expected
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
buy
Baozun Inc ADR

Start price
Target price
Perf. (%)
€22.00
29.07.21
€20.00
29.07.22
-32.27%
01.11.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
Phunware Inc.

Start price
Target price
Perf. (%)
€8.48
22.10.21
€12.00
22.10.22
-56.81%
01.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Tesla Inc

Start price
Target price
Perf. (%)
€236.13
12.01.21
€156.67
12.01.22
39.72%
01.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
High valuation
Tilray Inc

Start price
Target price
Perf. (%)
€9.55
03.10.21
-
03.10.22
-3.92%
01.11.21

Revenue growth >5% per year expected
Probably not worthwhile Investment
Below average Management
No Innovation
Brenntag SE

Start price
Target price
Perf. (%)
€74.74
01.05.21
€72.00
01.05.22
10.97%
01.11.21

Could be worthwhile Investment >10% per year
buy
Biora Therapeutics Inc.

Start price
Target price
Perf. (%)
€46.50
18.10.21
€90.00
18.10.22
68.82%
01.11.21

Could be very worthwhile Investment >20% year